SCHEMBL3133011

SCHEMBL3133011

CCN1C(=O)S/C(=C/c2ccc(-c3ccccc3)o2)C1=S

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ITGB2 P05107 3/20 0.60
ITGAM P11215 3/20 0.60
POLB P06746 3/20 0.59
RAB9A P51151 3/20 0.59
ALDH1A1 P00352 2/20 0.59
MAPT P10636 2/20 0.59
LMNA P02545 1/20 0.59
STAT3 P40763 1/20 0.56
PIK3CG P48736 1/20 0.51
TNFRSF1A P19438 1/20 0.49
EP300 Q09472 1/20 0.48
CREBBP Q92793 1/20 0.48
MEN1 O00255 3/20 0.48
KMT2A Q03164 3/20 0.48
NPC1 O15118 2/20 0.48
L3MBTL1 Q9Y468 2/20 0.48
GPR55 Q9Y2T6 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
CDC25B P30305 1/20 0.46
PSMB8 P28062 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3133014 1.00 ITGB2 (0.60) ITGB2ITGAMPOLBRAB9AALDH1A1
SCHEMBL3133007 1.00 ITGB2 (0.60) ITGB2ITGAMPOLBRAB9AALDH1A1
SCHEMBL3128520 0.92 RAB9A (0.61) ITGB2ITGAMPOLBRAB9AALDH1A1
SCHEMBL3128532 0.92 RAB9A (0.61) ITGB2ITGAMPOLBRAB9AALDH1A1
SCHEMBL3128525 0.92 RAB9A (0.61) ITGB2ITGAMPOLBRAB9AALDH1A1
SCHEMBL17088410 0.88 ITGB2 (0.71) ITGB2ITGAMPOLBRAB9AALDH1A1
SCHEMBL3135868 0.87 MAPT (0.55) ITGB2ITGAMPOLBRAB9AALDH1A1
SCHEMBL3135876 0.87 MAPT (0.55) ITGB2ITGAMPOLBRAB9AALDH1A1
SCHEMBL3135883 0.87 MAPT (0.55) ITGB2ITGAMPOLBRAB9AALDH1A1
SCHEMBL3131279 0.87 MEN1 (0.48) ITGB2ITGAMPOLBRAB9AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120219613-A1 Novel Antiviral Agents for Enveloped Viruses THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2012-08-30 US claimed
WO-2010044924-A1 NOVEL ANTIVIRAL AGENTS FOR ENVELOPED VIRUSES THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2010-04-22 WO claimed
US-20120219613-A1 Novel Antiviral Agents for Enveloped Viruses THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2012-08-30 US disclosed
WO-2010044924-A1 NOVEL ANTIVIRAL AGENTS FOR ENVELOPED VIRUSES THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2010-04-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120219613-A1 Novel Antiviral Agents for Enveloped Viruses MAVS, LAMP1, HAVCR2 ITGB2 2507/4885ITGAM 999/4885POLB 4238/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.